Active Ingredient: Afoxolaner
For this indication, competent medicine agencies globally authorize below treatments:
Oral, between 2.7 milligrams afoxolaner per kilogram of body weight and 7 milligrams afoxolaner per kilogram of body weight, once monthly.
The product should be administered at a dose of 2.7-6.9 mg/kg bodyweight in accordance with the following table:
| Bodyweight of dog (kg) | Strength and number of chewable tablets to be administered | |||
| afoxolaner 11 mg | afoxolaner 28 mg | afoxolaner 68 mg | afoxolaner 136 mg | |
| 2–4 | 1 | |||
| >4–10 | 1 | |||
| >10–25 | 1 | |||
| >25–50 | 1 | |||
For dogs above 50 kg bodyweight, use an appropriate combination of chewable tablets of different/same strengths. The tablets should not be divided.
The tablets are chewable and palatable to most dogs. If the dog does not accept the tablets directly they may be administered with food.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
